Arcutis Biotherapeutics Inc (ARQT)
EBITDA Growth
243.48%
Quarterly · Period ending:
ARQT EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported243.48%period ending
Latest reported243.48%period ending
ARQT Quarterly EBITDA YoY % (-1385700.00% → 243.48%)
Year-over-year change
High-resolution chart · PNG
ARQT ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 243.4823% | |
| 66.4006% | |
| 580.9022% | |
| 133.0914% | |
| 73.3399% | |
| 31.4217% | |
| 92.332% | |
| 0.5415% | |
| 29.1277% | |
| 62.5559% | |
| 10.2614% | |
| 67.0373% | |
| 3.0574% | |
| -16.618% | |
| 9.0364% | |
| -80.3039% | |
| -55.7154% | |
| -73.4253% | |
| -109.2039% | |
| -48.5747% | |
| -18.4331% | |
| -28.4356% | |
| -174.0517% | |
| -161.6242% | |
| -314.4547% | |
| -303.955% | |
| -73,245% | |
| -1,707,500% | |
| -1,385,700% |